Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stock Market Today: Dow resumes record run as dip buyers pile into tech

Published 02/01/2024, 08:00 PM
Updated 02/02/2024, 05:26 AM
© Reuters.

Investing.com -- The Dow closed higher Thursday, notching a fresh record closing high as the Federal Reserve-led selloff from a day earlier attracted dip-buying in tech stocks ahead of the all-important monthly jobs report due Friday. 

By 16:00 ET (21:00 GMT), the Dow Jones Industrial Average was up 369 points, or 1%, hitting a fresh record close of 38,519.84.  The S&P 500 traded 1.2% higher and Nasdaq Composite climbed 1.3%.

Amazon, Apple (NASDAQ:AAPL) and Meta set to report

Tech stocks rebounded to lead a sea of green across stocks as investors appeared to pile into stocks that were beaten down a day earlier after the Fed on Wednesday shot down hopes of a March cut. 

In afterours trading Thursday, Amazon (NASDAQ:AMZN) and Facebook-owner Meta Platforms (NASDAQ:META) jumped after quarterly results beat Wall Street estimates. 

Semiconductor stocks were slightly higher, but a nearly 5% slip in Qualcomm (NASDAQ:QCOM) kept a lid on gains in the sector, though investor concerns about maturing 5G smartphone market and loss of market share weighed on stock.  

"[T]he success that it had in the first few years of 5G creates a tough bar for further growth," Morgan Stanley said in a note.

Peloton sinks as guidance triggers bearish bets; Merck impresses on earnings stage

Peloton Interactive (NASDAQ:PTON) stock slumped 24% after the fitness company offered a weak outlook for revenue and free cash flow, while Royal

Royal Caribbean Cruises (NYSE:RCL) gave up early gains to end just below the flatline even as the cruise operator reported quarterly results and guidance that topped Wall Street estimates amid robust demand for cruise vacations. 

Merck (NYSE:MRK) stock rose over 4% after the drugmaker posted better-than-expected fourth-quarter results on strong sales of its cancer immunotherapy Keytruda, now the world's biggest selling prescription medicine.

Jobless claims tick up ahead of monthly payrolls 

Initial jobless claims rose to 224,000 in the week ended Jan. 27, up from an upwardly revised 215,000 and the highest level since Mid-November. 

"We expect that more strain is going to become evident, especially as middle class household deal with slowing wage gains and inflation fatigue," Jefferies said in a Thursday note. 

The rise in jobless claims comes just a day ahead of the monthly non-farm payrolls report that is expected to show a fall in the number of jobs created last month.  

The Federal Reserve kept interest rates on hold at more than two-decade highs on Wednesday, as widely expected, but Chair Jerome Powell prompted a hefty selloff after he reined in hopes that the central bank would soon start to cut interest rates.

"We estimate payrolls rose 215,000 in January, the unemployment," {{0|Morgan Stanley said, with wage growth expected to grow 0.3% on the month. 

(Peter Nurse contributed to this report.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.